Prior Authorization — Confirm Requirements

Prior authorization governance: Providers should confirm whether prior authorization (PA) is required for specific high-complexity or multiplex tests prior to ordering. Coverage determinations in this policy may interface with PA processes; PA requirements and submission instructions are governed by the member's specific plan and Health Plan administrative procedures.

• Confirm PA requirements for high-complexity or multiplex molecular panels (including tests identified by proprietary or U-codes).
• Submit clinical justification and required documentation with any PA request per Health Plan instructions.

Investigational Tests — Denial Risk

Investigational tests may trigger denial: Expanded multiplex panels (>6 targets), molecular/multiplex UTI panels, and other tests designated investigational in this policy are subject to denial when submitted for indications not supported by the policy.

• Expanded multiplex vaginitis/vaginosis panels with more than six targets (investigational).
• Molecular/multiplex UTI panels (investigational).
• Other targeted tests flagged investigational in the coding/coverage sections (see policy coding implications).

Urine Culture for ASB — Denial Risk

Urine culture for asymptomatic bacteriuria (ASB): Ordering urine cultures for ASB outside of the medically necessary indications listed in this policy may be denied.

• Urine culture for ASB is considered medically necessary only for pregnant members or members undergoing endoscopic urologic procedures with mucosal trauma.
• Urine cultures for ASB outside these indications are investigational and may be denied.

Documentation and Coverage Governance

Documentation and coverage governance: Providers must follow the coverage terms in the member's benefit plan and retain clinical documentation supporting medical necessity per contract and regulatory requirements.

• Maintain and provide, upon request, clinical records that demonstrate the symptomatic findings, indications, and rationale for testing.
• Coverage decisions are subject to plan terms, exclusions, state and federal requirements, and Health Plan administrative policies.

Required Clinical Documentation

Required clinical documentation: To support testing for vaginitis/vaginosis or urine culture, document the presence of relevant symptoms and findings.

• For vaginitis/vaginosis testing: abnormal vaginal discharge, vulvovaginal itching/irritation/redness, dyspareunia, dysuria, or postcoital/contact bleeding.
• For urine culture (ASB) testing: pregnancy status or planned endoscopic urologic procedure with mucosal trauma.
• Include pertinent exam findings, symptom onset/duration, and any prior test results or prior treatments tried.

Coverage Administrative Constraints

Coverage administrative constraints: Coverage is subject to member-specific benefit terms and may vary by contract; the Health Plan may change or withdraw this policy and apply additional administrative rules.

• Verify member eligibility and benefits prior to ordering.
• Policy effective/posting dates and any regulatory requirements govern applicability; when discrepancies exist, law/regulation prevails.